339 related articles for article (PubMed ID: 18339868)
1. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition.
Dang DT; Chun SY; Burkitt K; Abe M; Chen S; Havre P; Mabjeesh NJ; Heath EI; Vogelzang NJ; Cruz-Correa M; Blayney DW; Ensminger WD; St Croix B; Dang NH; Dang LH
Cancer Res; 2008 Mar; 68(6):1872-80. PubMed ID: 18339868
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts.
Dang DT; Chen F; Gardner LB; Cummins JM; Rago C; Bunz F; Kantsevoy SV; Dang LH
Cancer Res; 2006 Feb; 66(3):1684-936. PubMed ID: 16452228
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
[TBL] [Abstract][Full Text] [Related]
5. Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma.
Liu F; Wang P; Jiang X; Tan G; Qiao H; Jiang H; Krissansen GW; Sun X
Cancer Sci; 2008 Oct; 99(10):2055-61. PubMed ID: 19016766
[TBL] [Abstract][Full Text] [Related]
6. Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth.
Cao Y; Sonveaux P; Liu S; Zhao Y; Mi J; Clary BM; Li CY; Kontos CD; Dewhirst MW
Cancer Res; 2007 Apr; 67(8):3835-44. PubMed ID: 17440098
[TBL] [Abstract][Full Text] [Related]
7. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of hypoxia-inducible factor-1 alpha in RPMI8226 myeloma cells results in reduced tumor growth in nude mice].
Li BZ; Zhuang WZ; Chen P; Fu JX
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):247-51. PubMed ID: 18843979
[TBL] [Abstract][Full Text] [Related]
9. Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes.
Straight AM; Oakley K; Moores R; Bauer AJ; Patel A; Tuttle RM; Jimeno J; Francis GL
Cancer Chemother Pharmacol; 2006 Jan; 57(1):7-14. PubMed ID: 16001179
[TBL] [Abstract][Full Text] [Related]
10. Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1.
Bae MK; Kim SH; Jeong JW; Lee YM; Kim HS; Kim SR; Yun I; Bae SK; Kim KW
Oncol Rep; 2006 Jun; 15(6):1557-62. PubMed ID: 16685395
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.
Potiron VA; Sharma G; Nasarre P; Clarhaut JA; Augustin HG; Gemmill RM; Roche J; Drabkin HA
Cancer Res; 2007 Sep; 67(18):8708-15. PubMed ID: 17875711
[TBL] [Abstract][Full Text] [Related]
12. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
Ngan BY; Forte V; Campisi P
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin disrupts hypoxia-inducible factor signaling in ovarian cancer cells.
Hale SA; Wong C; Lounsbury KM
Gynecol Oncol; 2006 Jan; 100(1):14-9. PubMed ID: 16226302
[TBL] [Abstract][Full Text] [Related]
14. [The hypoxia-inducible factor HIF as a new target in cancer research].
L'Allemain G
Bull Cancer; 2002 Mar; 89(3):257-60. PubMed ID: 11940464
[TBL] [Abstract][Full Text] [Related]
15. Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation.
Cao Y; Li CY; Moeller BJ; Yu D; Zhao Y; Dreher MR; Shan S; Dewhirst MW
Cancer Res; 2005 Jul; 65(13):5498-505. PubMed ID: 15994919
[TBL] [Abstract][Full Text] [Related]
16. Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors.
Verheul HM; Salumbides B; Van Erp K; Hammers H; Qian DZ; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2008 Jun; 14(11):3589-97. PubMed ID: 18519793
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.
Kong D; Okamura M; Yoshimi H; Yamori T
Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-stimulated vascular endothelial growth factor production in human nasal polyp fibroblasts: effect of epigallocatechin-3-gallate on hypoxia-inducible factor-1 alpha synthesis.
Lin SK; Shun CT; Kok SH; Wang CC; Hsiao TY; Liu CM
Arch Otolaryngol Head Neck Surg; 2008 May; 134(5):522-7. PubMed ID: 18490575
[TBL] [Abstract][Full Text] [Related]
19. LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice.
Keyes KA; Mann L; Sherman M; Galbreath E; Schirtzinger L; Ballard D; Chen YF; Iversen P; Teicher BA
Cancer Chemother Pharmacol; 2004 Feb; 53(2):133-40. PubMed ID: 14593497
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor-1alpha (HIF-1alpha), and microvessel density in endometrial tissue in women with adenomyosis.
Goteri G; Lucarini G; Montik N; Zizzi A; Stramazzotti D; Fabris G; Tranquilli AL; Ciavattini A
Int J Gynecol Pathol; 2009 Mar; 28(2):157-63. PubMed ID: 19188818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
